Oncopeptides AB (publ)
SSE:ONCO.ST
Overview | Financials
Company Name | Oncopeptides AB (publ) |
Symbol | ONCO.ST |
Currency | SEK |
Price | 7.264 |
Market Cap | 656,953,465 |
Dividend Yield | 0% |
52-week-range | 6.21 - 12.4 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Jakob Lindberg Med. Lic |
Website | https://www.oncopeptides.com/sv |
An error occurred while fetching data.
About Oncopeptides AB (publ)
Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally. Its lead product candidate is melflufen, an anti-cancer peptide drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. Oncopeptides AB (publ) was incorporated in 2000
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD